134 related articles for article (PubMed ID: 30496637)
1. A pH-Responsive Glycyrrhetinic-Acid-Modified Small-Molecule Conjugate for NIR Imaging of Hepatocellular Carcinoma (HCC).
Singh H; Lim JY; Sharma A; Yoon DW; Kim JH; Yang Z; Qu J; Kim J; Lee SG; Kim JS
Chembiochem; 2019 Feb; 20(4):614-620. PubMed ID: 30496637
[TBL] [Abstract][Full Text] [Related]
2. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability.
Wang L; Wang X; Chen F; Song YQ; Nao SC; Chan DS; Wong CY; Wang W; Leung CH
Eur J Med Chem; 2024 Jan; 264():115995. PubMed ID: 38043488
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake mechanism and clearance kinetics of fluorescence-labeled glycyrrhetinic acid and glycyrrhetinic acid-modified liposome in hepatocellular carcinoma cells.
Sun Y; Lu J; Yan D; Shen L; Hu H; Chen D
Environ Toxicol Pharmacol; 2017 Jul; 53():46-56. PubMed ID: 28501784
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.
Sun Y; Dai C; Yin M; Lu J; Hu H; Chen D
Int J Nanomedicine; 2018; 13():1621-1632. PubMed ID: 29588589
[TBL] [Abstract][Full Text] [Related]
6. A near-infrared neutral pH fluorescent probe for monitoring minor pH changes: imaging in living HepG2 and HL-7702 cells.
Tang B; Yu F; Li P; Tong L; Duan X; Xie T; Wang X
J Am Chem Soc; 2009 Mar; 131(8):3016-23. PubMed ID: 19199620
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
Lv Y; Li J; Chen H; Bai Y; Zhang L
Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid.
Li J; Chen T; Deng F; Wan J; Tang Y; Yuan P; Zhang L
Int J Nanomedicine; 2015; 10():5475-87. PubMed ID: 26346750
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
12. Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells.
Sun YQ; Dai CM; Zheng Y; Shi SD; Hu HY; Chen DW
Life Sci; 2017 Nov; 188():186-191. PubMed ID: 28768154
[TBL] [Abstract][Full Text] [Related]
13. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.
Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J
EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy.
Qu Y; Sun F; He F; Yu C; Lv J; Zhang Q; Liang D; Yu C; Wang J; Zhang X; Xu A; Wu J
Eur J Pharm Sci; 2019 Nov; 139():105036. PubMed ID: 31446078
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells.
Tang ZH; Li T; Chang LL; Zhu H; Tong YG; Chen XP; Wang YT; Lu JJ
J Agric Food Chem; 2014 Dec; 62(49):11910-6. PubMed ID: 25403108
[TBL] [Abstract][Full Text] [Related]
16. Acid-sensitive polymeric vector targeting to hepatocarcinoma cells via glycyrrhetinic acid receptor-mediated endocytosis.
Yan T; Cheng J; Liu Z; Cheng F; Wei X; Huang Y; He J
Mater Sci Eng C Mater Biol Appl; 2018 Jun; 87():32-40. PubMed ID: 29549947
[TBL] [Abstract][Full Text] [Related]
17. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M
Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
20. A new near-infrared neutral pH fluorescent probe for monitoring minor pH changes and its application in imaging of HepG2 cells.
Sun C; Wang P; Li L; Zhou G; Zong X; Hu B; Zhang R; Cai J; Chen J; Ji M
Appl Biochem Biotechnol; 2014 Jan; 172(2):1036-44. PubMed ID: 24142355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
